Immediate Impact
8 standout
Citing Papers
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Works of Andy Beck being referenced
Abstract 5616: Tumor-targeted immune activation via a site-specific TLR7-agonist antibody-drug conjugate
2022
Abstract PO-072: Robust deployment of ML models quantifying the H&E tumor microenvironment in NSCLC subjects from an AstraZeneca-sponsored phase II clinical trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Andy Beck | 2 | 1 | 2 | 2 | 5 | 7 | ||
| Olga Kuchar | 2 | 2 | 1 | 5 | 7 | |||
| D. Steele | 2 | 1 | 2 | 5 | 7 | |||
| F Quarta | 2 | 1 | 2 | 5 | 9 | |||
| M. H. Gu | 1 | 2 | 2 | 2 | 5 | 6 | ||
| Alexander Brace | 2 | 2 | 4 | 6 | ||||
| H. Weiss | 3 | 2 | 4 | 7 | ||||
| Amr Eed | 2 | 3 | 4 | 6 | ||||
| Anton Sokhan | 1 | 1 | 2 | 5 | 7 | |||
| P. Miranda-Romagnoli | 2 | 1 | 5 | 7 | ||||
| Hui Zhi | 2 | 5 | 7 |
All Works
Loading papers...